Bed Bath & Beyond (BBBY) put volume and IV increases into Q2

Go back to Bed Bath & Beyond (BBBY) put volume and IV increases into Q2

Bed Bath & Beyond (BBBY) PT Lowered to $22 at BofA/Merrill Lynch Following 2Q

September 20, 2017 9:26 AM EDT

BofA/Merrill Lynch lowered its price target on Bed Bath & Beyond (NASDAQ: BBBY) to $22.00 (from $27.00) while maintaining a Underperform rating following the company's 2Q earnings release. BBBY reported 2Q EPS of $0.67 vs. $1.11 LY and below $0.94 estimates. GM decreased 99bp, and SG&A deleveraged... More

Bed Bath & Beyond (BBBY) PT Lowered to $30 at Barclays Following 2Q

September 20, 2017 8:47 AM EDT

Barclays lowered its price target on Bed Bath & Beyond (NASDAQ: BBBY) to $30.00 (from $40.00) while maintaining a Equalweight rating as the company begins transformational initiatives outlined on the 2Q17 earnings call.

BBBY reported 2Q17 EPS of $0.67. Barclays lowered FY17E and FY18E EPS to $3.00 and $3.00, from $4.00 and $4.10, respectively.

... More

Bed Bath & Beyond (BBBY) Halted, News Pending

September 19, 2017 4:10 PM EDT

Bed Bath & Beyond (NASDAQ: BBBY) Halted, News Pending

... More